CytoImmune Therapeutics
PrivateLast Round
Series A
Aug 6, 2021
Total Funding Raised
$36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CytoImmune Therapeutics is a clinical-stage biotechnology company that develops engineered natural killer (NK) cell-based cancer immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoImmune Therapeutics Comparables
Compare CytoImmune Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ONK Therapeutics | 87% | |
| Shoreline Biosciences | 86% | |
| Artiva | 78% | |
CytoImmune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 6, 2021 |
Key People
Founding team and executive leadership
CytoImmune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofinnova Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 89% MoM.
- Apr 4, 2026
Monthly visitors increased 832% MoM.
CytoImmune Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CytoImmune Therapeutics's valuation, stock price, and market status.